Bariatric–metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trialOrnella Verrastro, Geltrude Mingrone, Francesco Pennestrì et al.|The Lancet|2023Cited by 338
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosisGiulia Angelini, Geltrude Mingrone, Simona Panunzi et al.|Gut|2022Cited by 55
Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic SurgeryMaria Francesca Russo, Geltrude Mingrone, Erminia Lembo et al.|The Journal of Clinical Endocrinology & Metabolism|2020Cited by 27
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetesErminia Lembo, Esmeralda Capristo, Maria Francesca Russo et al.|Diabetes & Metabolism|2022Cited by 22